The addition of Rituximab to high dose sequential chemotherapy (HDS) programs with autologous transplantation significantly improves the outcome of patients with refractory or relapsed B-cell non Hogkin's lymphoma.

被引：0
|
作者：
Cortelazzo, S [1 ]
Rossi, A [1 ]
Carlotti, E [1 ]
Viero, P [1 ]
Rambaldi, A [1 ]
Barbui, T [1 ]
机构：
[1] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.2084.2084
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2084
引用
收藏
页码：589A / 590A
页数：2
相关论文
共 50 条
  • [1] Favorable influence of rituximab with high dose sequential chemotherapy (R-HDS) programs and autologous stem cell transplantation (ASCT) in salvage treatment for patients with refractory or relapsed B-cell non-Hodgkin's lymphoma.
    Pintimalli, Milena
    Mian, Michael
    Rossi, Andrea
    Sorio, Marco
    Benedetti, Fabio
    Pizzolo, Giovanni
    Billio, Atto
    Barbui, Tiziano
    Rambaldi, Alessandro
    Cortelazzo, Sergio
    BLOOD, 2006, 108 (11) : 776A - 776A
  • [2] High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma
    Oyan, Basak
    Koc, Yener
    Ozdemir, Evren
    Kars, Ayse
    Turker, Alev
    Tekuzman, Gulten
    Kansu, Emin
    LEUKEMIA & LYMPHOMA, 2006, 47 (08) : 1545 - 1552
  • [3] High dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma.
    Holland, D. W.
    Engelhardt, B. G.
    Goodman, S. A.
    Greer, J. P.
    Morgan, D. S.
    Schuening, F. G.
    Wolff, S.
    Bitting, R.
    Sulur, P.
    Stein, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 434S - 434S
  • [4] High-dose sequential (HDS) chemotherapy as salvage treatment in 33 patients with refractory or relapsed non-Hodgkin's lymphoma.
    Tarella, C
    Caracciolo, D
    Gavarotti, P
    Corradini, P
    Zallio, F
    Castellino, C
    Pileri, A
    BLOOD, 1996, 88 (10) : 3881 - 3881
  • [5] Comparison of the sequential high-dose chemotherapy followed by autologous stem cell support with and without rituximab in relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Sieniawski, M
    Staak, JO
    Scheuss, H
    Glossmann, JP
    Diehl, V
    Engert, A
    Josting, A
    BLOOD, 2004, 104 (11) : 263A - 263A
  • [6] High dose chemotherapy and autologous hematopoietic progenitor cell support in patients with refractory or relapsed lymphoma.
    Keohan, ML
    Papadopoulos, KP
    Vahdat, LH
    Savage, DS
    Garrett, TJ
    Antman, KH
    Hesdorffer, CS
    BLOOD, 1997, 90 (10) : 4562 - 4562
  • [7] High Dose Sequential Chemotherapy (HDS) improves the outcome of patients with disseminated Mantle Cell Lymphoma (MCL)
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Conconi, A
    Tarella, C
    Benedetti, F
    Devizzi, L
    Martelli, M
    Zinzani, PL
    Gianni, AM
    Barbui, T
    BONE MARROW TRANSPLANTATION, 2001, 27 : S259 - S259
  • [8] High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
    Alkhaldi, Hanan
    Reinhardt, Alec
    Barnett, Melissa
    Kundu, Suprateek
    Hosing, Chitra
    Ramdial, Jeremy
    Saini, Neeraj
    Srour, Samer
    Alousi, Amin
    Kebriaei, Partow
    Popat, Uday
    Qazilbash, Muzaffar
    Champlin, Richard
    Shpall, Elizabeth J.
    Gulbis, Allison
    Shigle, Terri Lynn
    Dabaja, Bouthaina
    Pinnix, Chelsea
    Ahmed, Sairah
    Steiner, Raphael
    Andersson, Borje S.
    Nieto, Yago
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 690 - 694
  • [9] High-dose sequential (RDS) chemotherapy with high-dose ARA-C and Rituximab prolongs the survival of patients with resistant/relapsed B-cell non-Hodgkin's lymphoma.
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Bellavita, P
    Motta, T
    Barbui, T
    BLOOD, 2002, 100 (11) : 646A - 646A
  • [10] The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma
    Ferreri, Andres J. M.
    Dognini, Giuseppina P.
    Bairey, Osnat
    Szomor, Arpad
    Montalban, Carlos
    Horvath, Barbara
    Demeter, Judit
    Uziel, Lilj
    Soffietti, Riccardo
    Seymour, John F.
    Ambrosetti, Achille
    Willemze, Rein
    Martelli, Maurizio
    Rossi, Giuseppe
    Candoni, Anna
    De Renzo, Amalia
    Doglioni, Claudio
    Zucca, Emanuele
    Cavalli, Franco
    Ponzoni, Maurilio
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (02) : 253 - 257
12345